Sign In
Buy ACOR
$0.661
+0 (+0%)
At Close: Jul 10, 2024
Acorda Reports Second Quarter 2020 Financial Results
08:00pm, Tuesday, 04'th Aug 2020
Acorda Therapeutics, Inc. (NASDAQ: ACOR) today provided a business update and reported its financial results for the second quarter ended June 30, 2020.
FDA Issues Emergency Use Authorization for Impella Heart Pumps to Provide Unloading Therapy to COVID-19 Patients
12:00am, Tuesday, 04'th Aug 2020
The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide lef
The Week Ahead In Biotech: Novavax Coronavirus Vaccine Readout, FDA Decisions And More Earnings
12:00am, Sunday, 02'nd Aug 2020
Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.
COVID-19 news flow continued to pour in,...
Acorda Therapeutics Announces Adjournment of Special Meeting of Stockholders
04:45pm, Friday, 31'st Jul 2020
Acorda Therapeutics, Inc. (Nasdaq: ACOR) convened its Special Meeting of Stockholders on July 31, 2020, and stockholders approved proposals to authorize the Company’s Board of Directors to implement
Best Chance Products, LLC, a distribution and sales company providing a supply chain of personal protective equipment, has been named the exclusive di
Acorda Second Quarter 2020 Update: Webcast/Conference Call Scheduled for August 4, 2020
11:00am, Tuesday, 28'th Jul 2020
Acorda Therapeutics, Inc. (NASDAQ: ACOR) will host a conference call and webcast in conjunction with its second quarter 2020 update and financial results on Tuesday, August 4 at 4:30 p.m. ET.
The Daily Biotech Pulse: Moderna To Kickstart Phase 3 Study On July 27, Immutep Awarded Antibody Patent
12:00am, Wednesday, 15'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 14)
Altimmune Inc (NASDAQ: ALT...
Cipla gets USFDA nod for rare genetic condition treatment drug
11:14am, Tuesday, 14'th Jul 2020
Cipla's Icatibant injectable pre-filled syringe in the strength of 30mg/3mL is generic version of Shire's Firazyr, the company said in a regulatory filing.
Do Hedge Funds Love Acorda Therapeutics Inc (ACOR)?
10:40pm, Wednesday, 08'th Jul 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
Nemaura Medical Submits PMA Application for sugarBEAT® to U.S. FDA
12:00am, Tuesday, 07'th Jul 2020
Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing micro-systems-based wearable dia
Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial
05:39pm, Monday, 06'th Jul 2020
The medicine has been issued an Emergency Use Authorization (EUA) by the United States Food and Drug Administration (USFDA) to treat COVID-19 patients.
AMGN Stock Jumped 8%, Amgen Beats Novartis in Patent Battle
02:19pm, Thursday, 02'nd Jul 2020
U.S.-based pharmaceutical giant Amgen wins Appeal Court ruling upholding the patent of its drug Enbrel, Amgen (AMGN) stock is up.
